News & Updates
Stay up to date with the latest VAXgpo announcements, partnerships, industry insights, and important updates for our members.
News & Updates
AAP Recommends All Young and High-Risk Children Get Vaccinated Against COVID-19
The American Academy of Pediatrics (AAP) has released immunization guidance, strongly advising that all children aged 6–23 months receive the COVID‑19 vaccine
The AAP recommends all young children ages 6-23 months get vaccinated against COVID-19 along with older children in certain risk groups, based on evidence on who can benefit the most from the vaccine. The guidance differs from federal policy that removes routine recommendations for healthy children but allows vaccination after a conversation with a health care provider.
ACIP Recommends Use of Merck's ENFLONSIA™ (clesrovimab-cfor) for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Disease in Infants Younger than 8 Months of Age Born During or Entering Their First RSV Season
The Advisory Committee on Immunization Practices (ACIP) has recommended Merck's ENFLONSIA™ for RSV prevention in infants.
The Advisory Committee on Immunization Practices (ACIP) to the CDC has voted to recommend the use of ENFLONSIA™ (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in infants younger than 8 months of age who are born during or entering their first RSV season. This recommendation represents a significant advancement in protecting vulnerable infants from RSV disease.
Need Additional Support?
Can't find what you're looking for? Our team is here to help with any questions or additional resources you may need.